Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

When Bombay DC revamped the Aquaguard logo, it realised that consumers associated ... way that they wouldn’t have in the past. Take the GSK rebrand in 2022. Ten, or 20 years ago, nobody would ...

The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless ...

CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies connect ...

Khurem Farooq, formerly chief executive of Aiolos Bio and Gyroscope Therapeutics prior to their respective acquisitions by GSK and Novartis ... OrbiMed, Logos Capital, Lilly Asia Ventures ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

In a report released on February 5, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with ...

The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...

GSK PLC closed 18.56% below its 52-week high of £18.24, which the company reached on May 16th.

GSK PLC closed 24.32% short of its 52-week high of £18.24, which the company achieved on May 16th.

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...